Business Licence and the One-Stop Licensing Procedure in Macao

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The mandatory nature of the business licence is risk-tiered: import, export and wholesale of Class I and Class IIa devices do not require a business licence; import, export and wholesale of Class IIb and Class III devices require a business licence; retail of Class IIb devices requires a business licence, and retail of Class III devices is prohibited (Article 37 and the official promotional materials). A business licence is valid from the date of issue until 31 December of the following year, and must be renewed annually thereafter. The implementing rules establish a one-stop licensing procedure for the business licence, with participating entities including the Land and Public Works Bureau, the Fire Services Bureau, the Labour Affairs Bureau and the Cultural Affairs Bureau.

  • Class I and Class IIa import, export and wholesale fall outside the business licence requirement.
  • Class IIb and Class III import, export and wholesale require a business licence.
  • Class IIb retail requires a business licence; Class III retail is prohibited by law.
  • The licence runs from issue until 31 December of the following year and is renewed annually.
  • One-stop licensing brings several bureaus into a single parallel procedure.

2. Legal basis

The framework combines the parent law, the implementing rules, the fee schedule approved by the Chief Executive, and the promotional materials published by the ISAF. The table below lists the instruments and the provisions cited in this article.

Regulatory instrumentReferencePublication dateProvisions
Medical Devices Regulatory RegimeLaw No. 12/2025 (Official Gazette No. 30/2025)Published on 28 July 2025; effective on 1 July 2026Article 31 (categories of licences); Article 37 (mandatory nature of the business licence); Article 38 (requirements for issue or renewal and validity of the business licence); Article 39 (business rules for business premises); Article 66 (existing premises)
Implementing Rules of the Medical Devices Regulatory RegimeAdministrative Regulation No. 11/2026 (Official Gazette No. 20/2026)Published on 18 May 2026; effective on 1 July 2026Provisions on the one-stop licensing procedure (Land and Public Works Bureau 30 working days; Fire Services Bureau, Labour Affairs Bureau and Cultural Affairs Bureau 15 working days each; ISAF 15 working days; decision within 5 working days after all opinions are received); article on licence renewal (annual renewal of the business licence in December)
Dispatch of the Chief Executive No. 144/2026 approving the Fee Schedule for Medical Device Business Activities and Medical Device RegistrationDispatch of the Chief Executive No. 144/2026 (Official Gazette No. 24/2026)Published on 15 June 2026; effective on 1 July 2026Table 1, item 1.2 (issue of a business licence, MOP 2,000); item 2.2 (renewal, MOP 300)
Industry promotional materials of the Drug Supervision AdministrationDocuments published by the ISAFCurrent version, verified as of 2026-10-29Statements on licence requirements per classification and on the prohibition of retail of Class III devices

3. Expert insights

Insight one: the prohibition of retail of Class III devices is a hard constraint on the business model. The authorities make clear that Class III medical devices may by law only be supplied to healthcare establishments such as hospitals and clinics, and to research institutions. This is not a channel preference but a statutory restriction — companies whose portfolios involve coronary stents, implantable pacemakers, artificial joints, AEDs and similar products must design their business plans around direct sales to institutions.

Insight two: one-stop licensing is an administrative efficiency highlight, but many entities participate in parallel. The implementing rules provide: opinion of the Land and Public Works Bureau 30 working days; Fire Services Bureau, Labour Affairs Bureau and Cultural Affairs Bureau 15 working days each; ISAF 15 working days; and the ISAF decides within 5 working days after all opinions are received. A technical meeting may also be convened within 5 working days after receipt of the last opinion. The critical path is determined by the slowest participating entity.

Insight three: the correction window is extremely short. The implementing rules provide that participating entities notify omissions within 5 working days from receipt of the application; the ISAF notifies the applicant within 2 working days from becoming aware of the omissions and sets the period for correction; if the correction is not made in time, the application is not accepted. This is a compact process counted in working days.

Insight four: the works licence and inspection carry time pressure. After the plans are approved, the applicant must submit the inspection application within 6 months from receipt of the notification (one extension of the same period may be requested); otherwise the approval lapses; the ISAF conducts the inspection within 15 working days from receipt of the application.

Insight five: the renewal rhythm differs from that of the manufacturing licence. The business licence is renewed every December (by declaring continued compliance with the conditions under which it was issued); the manufacturing licence is renewed 90 to 180 days before expiry. The renewal points of the two licences differ and must be set up as separate reminders.

4. Practical recommendations

  • Determine first whether a business licence is needed at all: import, export and wholesale of Class I and Class IIa devices do not require one, saving the MOP 2,000 fee and the entire licensing procedure.
  • Design channels for Class III products as direct sales to institutions: retail channels are legally not viable.
  • Schedule one-stop licensing around the slowest entity: treat the 30 working days of the Land and Public Works Bureau as the critical path.
  • Treat the 6-month inspection application period as a hard milestone: missing it causes the approval to lapse.
  • Handle renewal every December: manage it separately from the product registration renewal (90 to 180 day window).

5. Verification checklist

  • □ Confirmed whether a business licence is required by classification (Class IIb and Class III import, export and wholesale, and Class IIb retail, require one)
  • □ Channels for Class III products designed around the prohibition of retail
  • □ Deadlines of the participating entities in the one-stop procedure built into the schedule
  • □ Response mechanism for corrections established (notification within 2 working days, correction within the set period)
  • □ 6-month inspection application period set as a project milestone
  • □ Annual renewal reminder for December set up

Regulatory information verified as of 29 October 2026. The laws, guidelines and effective dates described in this article are limited to the content published by the official sources listed under Legal basis as of that date; where official documents are updated, the most recently published version prevails.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for Macao, China. Our team coordinates local licence holder arrangements, import and supply requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail